Brief: Caris Life Sciences, Prostate Cancer Clinical Trial Consortium And Sorrento Therapeutics To Collaborate
02/06/2022 11:48
June 2 (Reuters) - Sorrento Therapeutics Inc SRNE.O :
* CARIS LIFE SCIENCES, PROSTATE CANCER CLINICAL TRIAL
CONSORTIUM
AND SORRENTO THERAPEUTICS ANNOUNCE COLLABORATION TO ADVANCE
PRECISION MEDICINE DEVELOPMENT USING COMPREHENSIVE GENOMIC
PROFILING
Source text for Eikon: ID:nPn9Z5Y0Va
Further company coverage: SRNE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sorrento Therapeutics
See all newsBrief: Scilex Holding Says US Bankruptcy Court Extended Lockup Period On Shares Of Scilex Stock
Company's PO box allows it to file for bankruptcy in Texas, judge rules
Latham, Jackson Walker avoid sanctions over bankruptcy forum shopping dispute (updated)
Latham, Jackson Walker avoid sanctions over bankruptcy forum shopping dispute
Brief: Sorrento Therapeutics Reduced U.S. Headcount From 215 To 128 on Sept. 20